Diabetes Drug Metformin Found to Directly Influence the Brain
For more than six decades, metformin has been a cornerstone in the fight against type 2 diabetes, primarily thought to work by controlling glucose in the liver and the gut. Now, groundbreaking research is revealing an entirely new dimension: the drug doesn’t just act on the body, it works directly in the brain.
Researchers at the Baylor College of Medicine in the United States have uncovered evidence that metformin targets a specific brain pathway involving a protein called Rap1, located in the ventromedial hypothalamus, or VMH. This discovery could fundamentally change our understanding of how diabetes medications function. In mouse studies, metformin traveled to this region of the brain and effectively turned off Rap1, lowering blood glucose levels. Remarkably, when Rap1 was removed in experimental mice, metformin lost its effectiveness, even though other diabetes drugs continued to work.
The study also pinpointed the exact neurons involved—known as SF1 neurons—which appear to respond directly to metformin. This opens the possibility for future treatments that could target these brain cells more precisely, potentially enhancing the drug’s effects while minimizing side effects. Metformin, already recognized for its affordability and long-lasting action, has now shown promise for even broader applications.
Also Read:- Kristi Noem’s Top Aide Ousted Amid Controversial Latin America Tour
- Moana Pasifika Seeks Breakthrough Against Highlanders After Tough Run
Beyond diabetes management, this discovery links to metformin’s other known benefits. Earlier studies have suggested that the drug may slow brain aging, improve lifespan and even reduce the risk of long COVID. A 2025 study of over 400 postmenopausal women found that those taking metformin had a 30 percent lower risk of dying before the age of 90 compared with those on a different diabetes medication. Researchers believe the same Rap1 signaling pathway in the brain could be responsible for some of these age-related benefits.
While the findings are still primarily in animal models, the implications for human medicine are significant. Understanding how metformin interacts with the brain could lead to new therapies for diabetes, neurological health and potentially broader age-related conditions. However, it’s important to remember that metformin is not without side effects. Gastrointestinal issues are common and care must be taken in patients with kidney problems or other health risks.
This research challenges long-held assumptions and opens the door to a new era of diabetes treatment and brain health exploration. Scientists now have a clearer target and the next steps will be translating these findings into safe, effective therapies for humans.
Stay with us for ongoing updates as this story develops and follow for the latest breakthroughs in health and science that could reshape how we treat chronic diseases.
Read More:
0 Comments